(Q57148414)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24841294%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

title

Calorie restriction and Roux-en-Y gastric bypass have opposing effects on circulating FGF21 in morbidly obese subjects (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24841294%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24841294%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Bart A van Wagensveld

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24841294%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Adrianus Luijten

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24841294%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Hanno Pijl

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24841294%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Frank G. Schaap

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24841294%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

8

Ko Willems van Dijk

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24841294%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

author name string

Mirjam A Lips

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24841294%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Gerrit H de Groot

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24841294%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Renee Wiezer

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24841294%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Dingeman J Swank

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24841294%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Peter L M Jansen

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24841294%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

language of work or name

English

0 references

publication date

12 June 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24841294%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

published in

Clinical Endocrinology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24841294%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

volume

81

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24841294%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24841294%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

page(s)

862-870

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24841294%20AND%20SRC:MED&resulttype=core&format=json

The FGF family: biology, pathophysiology and therapy

18 March 2020

cites work

1 reference

Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states

21 January 2018

1 reference

Fibroblast growth factor-21 regulates PPARγ activity and the antidiabetic actions of thiazolidinediones.

21 January 2018

1 reference

The circulating metabolic regulator FGF21 is induced by prolonged fasting and PPARalpha activation in man.

21 January 2018

1 reference

FGF-21 as a novel metabolic regulator

21 January 2018

1 reference

Fibroblast growth factor 21 regulates energy metabolism by activating the AMPK-SIRT1-PGC-1alpha pathway

21 January 2018

1 reference

Circulating fibroblast growth factor-21 is elevated in impaired glucose tolerance and type 2 diabetes and correlates with muscle and hepatic insulin resistance.

21 January 2018

1 reference

Increased fibroblast growth factor 21 in obesity and nonalcoholic fatty liver disease

21 January 2018

1 reference

Relation between fibroblast growth factor-21, adiposity, metabolism, and weight reduction

21 January 2018

1 reference

Serum concentrations and tissue expression of a novel endocrine regulator fibroblast growth factor-21 in patients with type 2 diabetes and obesity.

21 January 2018

1 reference

FGF19 as a postprandial, insulin-independent activator of hepatic protein and glycogen synthesis

21 January 2018

1 reference

Activation of the farnesoid X receptor induces hepatic expression and secretion of fibroblast growth factor 21

21 January 2018

1 reference

Metabolic profiling of the human response to a glucose challenge reveals distinct axes of insulin sensitivity

21 January 2018

1 reference

Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes

21 January 2018

1 reference

Conjugated bile acids associate with altered rates of glucose and lipid oxidation after Roux-en-Y gastric bypass

21 January 2018

1 reference

Accuracy of prediction scores and novel biomarkers for predicting nonalcoholic fatty liver disease in obese children.

21 January 2018

1 reference

High expression of the bile salt-homeostatic hormone fibroblast growth factor 19 in the liver of patients with extrahepatic cholestasis

21 January 2018

1 reference

Physiological modulation of circulating FGF21: relevance of free fatty acids and insulin.

21 January 2018

1 reference

Direct effects of FGF21 on glucose uptake in human skeletal muscle: implications for type 2 diabetes and obesity.

21 January 2018

1 reference

Glucagon and lipid interactions in the regulation of hepatic AMPK signaling and expression of PPARα and FGF21 transcripts in vivo

21 January 2018

1 reference

Glucagon increases circulating fibroblast growth factor 21 independently of endogenous insulin levels: a novel mechanism of glucagon-stimulated lipolysis?

21 January 2018

1 reference

Fibroblast growth factor 21 mediates specific glucagon actions

21 January 2018

1 reference

Serum bile acids are higher in humans with prior gastric bypass: potential contribution to improved glucose and lipid metabolism

21 January 2018

1 reference

The role of bile after Roux-en-Y gastric bypass in promoting weight loss and improving glycaemic control

21 January 2018

1 reference

Two days of a very low calorie diet reduces endogenous glucose production in obese type 2 diabetic patients despite the withdrawal of blood glucose-lowering therapies including insulin

21 January 2018

1 reference

Fibroblast growth factor 21 is induced by endoplasmic reticulum stress

21 January 2018

1 reference

Activating transcription factor 4-dependent induction of FGF21 during amino acid deprivation.

21 January 2018

1 reference

Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice

21 January 2018

1 reference

The effects of LY2405319, an FGF21 analog, in obese human subjects with type 2 diabetes

21 January 2018

1 reference

Decrease in circulating fibroblast growth factor 21 after an oral fat load is related to postprandial triglyceride-rich lipoproteins and liver fat.

21 January 2018

1 reference

Intestinal adaptation after ileal interposition surgery increases bile acid recycling and protects against obesity-related comorbidities

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/CEN.12496

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24841294%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

1 reference